Key Findings:  The resulting data suggests that co-administration of MOR and CB1 agonists may enhance their antinociceptive effects.
Type of Study:  Animal Study
Study Result:  Positive
Research Location(s):  Japan
Year of Pub:  2022
Cannabinoids Studied:  CP-x Synthetic Cannabinoids, WIN-x Synthetic Cannabinoids
Phytocannabinoid Source:  Not Applicable
Receptors Studied:  CB1, Opioid Receptor Mu , CB1 agonist
Ligands Studied:  Endogenous opioids
Citation:  Takemura Y, et al. Involvement of spinal G-protein inwardly rectifying potassium (GIRK) channels in the enhanced antinociceptive effects of the activation of both μ-opioid and cannabinoid CB1 receptors. J Pharmacol Sci. 2022; 149:85-92. doi: 10.1016/j.jphs.2022.04.002
Authors:  Takemura Y, Sudo Y, Saeki T, Kurata S, Suzuki T, Mori T, Uezono Y